A detailed history of Black Rock Inc. transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 63,583 shares of RANI stock, worth $92,831. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,583
Previous 63,583 -0.0%
Holding current value
$92,831
Previous $197,000 22.34%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$5.51 - $10.02 $767,675 - $1.4 Million
-139,324 Reduced 68.66%
63,583 $375,000
Q3 2022

Nov 14, 2022

SELL
$8.23 - $12.4 $32,302 - $48,670
-3,925 Reduced 1.9%
202,907 $1.94 Million
Q2 2022

Aug 12, 2022

BUY
$8.0 - $14.25 $395,664 - $704,776
49,458 Added 31.43%
206,832 $2.14 Million
Q1 2022

May 12, 2022

BUY
$12.21 - $23.14 $525,957 - $996,778
43,076 Added 37.69%
157,374 $2.13 Million
Q4 2021

Feb 10, 2022

BUY
$16.09 - $35.0 $1.84 Million - $4 Million
114,298 New
114,298 $1.87 Million

Others Institutions Holding RANI

About Rani Therapeutics Holdings, Inc.


  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $35.8M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.